140
Participants
Start Date
November 30, 2016
Primary Completion Date
May 31, 2017
Study Completion Date
May 31, 2017
Permethrin Cream, 5%
Subjects on Test product will receive a maximum of two doses, 60 g each, during the study. The first dose will be applied on Day 1 in an outpatient setting, after the visit to the clinical site (preferably in the evening). The second dose will be applied on Day 14±2 only if retreatment is necessary.
Elimite
Subjects on RLD will receive a maximum of two doses, 60 g each, during the study. The first dose will be applied on Day 1 in an outpatient setting, after the visit to the clinical site (preferably in the evening). The second dose will be applied on Day 14±2 only if retreatment is necessary.
LCC Medical Research Institute, Miami
Southcoast Research Center, Miami
Mid Columbia Research, Richland
bioRASI, LLC
INDUSTRY
Mayne Pharma International Pty Ltd
INDUSTRY